|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 487/04 | (2013.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3782998 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19789509.7 |
| Date of filing the European patent application | 2019-04-15 | |
| (97) | Date of publication of the European application | 2021-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2019/082618 |
| Date | 2019-04-15 |
| (87) | Number | WO 2019/201194 |
| Date | 2019-10-24 |
| (30) | Number | Date | Country code |
| 201810339098 | 2018-04-16 | CN |
| (72) |
WANG, Yihan , CN
LI, Huanyin , CN
|
| (73) |
Shenzhen TargetRx, Inc. ,
Room 301 Unit 1 Building A
Kexing Science Park
No.15 of Keyuan Road
Nanshan District, Shenzhen, Guangdong 518057,
CN
|
| (54) | SUBSTITUTED PYRROLOTRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF |
| SUBSTITUTED PYRROLOTRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF |